Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Azenta Inc.

NAS: AZTA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Azenta Inc.

Market open

 --Real time quotes

Jun 9, 2023, 11:52 a.m.

AZTA
/zigman2/quotes/200082753/composite

$

45.33

Change

-0.10 -0.22%

Volume

Volume 209,233

Real time quotes

/zigman2/quotes/200082753/composite

Previous close

$ 45.43

$ 45.33

Change

-0.10 -0.22%

Day low

Day high

$45.04

$45.96

Open

52 week low

52 week high

$36.01

$78.15

Open

Company Description

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological ...

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Valuation

Price to Sales Ratio

5.78

Price to Book Ratio

0.96

Enterprise Value to EBITDA

34.30

Enterprise Value to Sales

1.70

Total Debt to Enterprise Value

0.04

Efficiency

Revenue/Employee

179,193.00

Income Per Employee

-3,641.00

Receivables Turnover

3.50

Total Asset Turnover

0.20

Liquidity

Current Ratio

10.67

Quick Ratio

10.30

Cash Ratio

8.47

Profitability

Gross Margin

41.52

Operating Margin

-4.32

Pretax Margin

-1.79

Net Margin

-2.03

Return on Assets

-0.41

Return on Equity

-0.48

Return on Total Capital

-0.99

Return on Invested Capital

-0.47

Capital Structure

Total Debt to Total Equity

1.68

Total Debt to Total Capital

1.65

Total Debt to Total Assets

1.52

Long-Term Debt to Equity

1.47

Long-Term Debt to Total Capital

1.44

Officers and Executives

Name Age Officer Since Title
Dr. Stephen S. Schwartz 63 2010 President, CEO & Executive Director
Mr. Robin Vacha - 2014 Senior Vice President-Global Operations
Mr. Lindon G. Robertson 61 2013 Chief Financial Officer & Executive Vice President
Mr. Michael Paulo - 2017 VP, Chief Information & Digital Officer
Mr. William T. Montone 70 2005 Senior Vice President-Human Resources

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/13/2023 Krishna G. Palepu
Director 		3,604   Award at $0 per share. 0
02/13/2023 Joseph R. Martin
Director 		5,268   Award at $0 per share. 0
02/13/2023 Ellen M. Zane
Director 		3,604   Award at $0 per share. 0
02/13/2023 Robyn C. Davis
Director 		3,604   Award at $0 per share. 0
02/13/2023 Michael A. Rosenblatt
Director 		3,604   Award at $0 per share. 0
02/13/2023 Erica J. McLaughlin
Director 		3,604   Award at $0 per share. 0
02/13/2023 Frank E. Casal
Director 		3,604   Award at $0 per share. 0
02/13/2023 Dorothy E. Puhy
Director 		3,604   Award at $0 per share. 0
02/13/2023 Tina Susan Nova
Director 		3,604   Award at $0 per share. 0
01/31/2023 Lindon G. Robertson
EVP & Chief Financial Officer 		279   Award at $46.92 per share. 13,090
01/31/2023 Robin Vacha
SVP, GM Life Science Products 		265   Award at $46.92 per share. 12,433
01/31/2023 Ginger Zhou
SVP and General Manager, Genom 		323   Award at $46.92 per share. 15,155
01/31/2023 Kimberly Crowley
SVP, Chief HR Officer 		177   Award at $46.92 per share. 8,304
01/31/2023 Vandana Sriram
SVP Finance & Corp. Controller 		369   Award at $46.92 per share. 17,313
11/17/2022 Stephen S. Schwartz
CEO; Director 		18,886   Award at $0 per share. 0
11/17/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		6,296   Award at $0 per share. 0
11/17/2022 Jason W. Joseph
SVP, General Counsel, Secy. 		3,778   Award at $0 per share. 0
11/17/2022 David C. Gray
Chief Strategy & New Business 		3,148   Award at $0 per share. 0
11/17/2022 Robin Vacha
SVP, GM Life Science Products 		3,778   Award at $0 per share. 0
11/17/2022 Ginger Zhou
SVP and General Manager, Genom 		1,889   Award at $0 per share. 0
11/17/2022 Kimberly Crowley
SVP, Chief HR Officer 		2,519   Award at $0 per share. 0
11/17/2022 Vandana Sriram
SVP Finance & Corp. Controller 		2,519   Award at $0 per share. 0
11/17/2022 Mitchell Coyne
SVP and GM, Life Sciences Proj 		1,889   Award at $0 per share. 0
11/15/2022 Stephen S. Schwartz
CEO; Director 		26,293   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		10,091   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Jason W. Joseph
SVP, General Counsel, Secy. 		4,535   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 David C. Gray
Chief Strategy & New Business 		5,235   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Robin Vacha
SVP, GM Life Science Products 		5,838   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Ginger Zhou
SVP and General Manager, Genom 		680   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Kimberly Crowley
SVP, Chief HR Officer 		574   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Vandana Sriram
SVP Finance & Corp. Controller 		81   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2022 Stephen S. Schwartz
CEO; Director 		48,580   Award at $0 per share. 0
11/15/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		20,403   Award at $0 per share. 0
11/15/2022 Jason W. Joseph
SVP, General Counsel, Secy. 		10,687   Award at $0 per share. 0
11/15/2022 David C. Gray
Chief Strategy & New Business 		10,200   Award at $0 per share. 0
11/15/2022 Robin Vacha
SVP, GM Life Science Products 		11,077   Award at $0 per share. 0
11/15/2022 Ginger Zhou
SVP and General Manager, Genom 		2,236   Award at $0 per share. 0
08/19/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		4,350   Acquisition at $57.62 per share. 250,647
08/19/2022 Matthew F. McManus
EVP & Chief Operating Officer 		8,625   Acquisition at $58.15 per share. 501,543
07/29/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		98   Award at $57.49 per share. 5,634
07/29/2022 Kimberly Crowley
SVP, Chief HR Officer 		144   Award at $57.49 per share. 8,278
07/29/2022 Vandana Sriram
SVP Finance & Corp. Controller 		292   Award at $57.49 per share. 16,787
07/29/2022 Jesus Linda De
Chief Commercial Officer, LS 		43   Award at $57.49 per share. 2,472
04/12/2022 Kimberly Crowley
SVP, Chief HR Officer 		132   Disposition at $78.02 per share. 10,298
02/11/2022 Mark Stephen Wrighton
Director 		1,922   Award at $0 per share. 0
02/11/2022 Krishna G. Palepu
Director 		1,922   Award at $0 per share. 0
02/11/2022 Joseph R. Martin
Director 		2,808   Award at $0 per share. 0
02/11/2022 Ellen M. Zane
Director 		1,922   Award at $0 per share. 0
02/11/2022 Robyn C. Davis
Director 		1,922   Award at $0 per share. 0
02/11/2022 Michael A. Rosenblatt
Director 		1,922   Award at $0 per share. 0
02/11/2022 Erica J. McLaughlin
Director 		1,922   Award at $0 per share. 0
02/11/2022 Frank E. Casal
Director 		1,922   Award at $0 per share. 0
01/31/2022 Lindon G. Robertson
EVP & Chief Financial Officer 		189   13,095
01/31/2022 Robin Vacha
SVP, GM Life Science Products 		285   Award at $69.29 per share. 19,747
01/31/2022 Kimberly Crowley
SVP, Chief HR Officer 		110   Award at $69.29 per share. 7,621
01/06/2022 Joseph R. Martin
Director 		1,000   Gift at $0 per share. 0
/news/latest/company/us/azta

MarketWatch News on AZTA

  1. Azenta downgraded to sector weight from overweight at KeyBanc Capital

    6:29 a.m. May 10, 2023

    - Tomi Kilgore

  3. Azenta announces $500 mln accelerated share buyback agreement with JP Morgan Chase

    8:17 a.m. Nov. 23, 2022

    - Ciara Linnane

  4. Azenta stock price target cut to $70 from $90 at KeyBanc Capital

    6:00 a.m. Oct. 24, 2022

    - Tomi Kilgore

  5. Azenta stock price target cut to $74 from $94 at Needham

    7:14 a.m. Aug. 10, 2022

    - Tomi Kilgore

  6. Stock Futures Down After Inflation Report

    7:20 p.m. July 13, 2022

    - Barron's Online

  7. Azenta stock price target cut to $90 from $132 at KeyBanc Capital

    6:35 a.m. May 10, 2022

    - Tomi Kilgore

  8. Azenta stock price target cut to $115 from $155 at Needham

    7:52 a.m. Feb. 9, 2022

    - Tomi Kilgore

  10. These are Wall Street’s 25 favorite semiconductor stocks for 2022

    8:13 a.m. Dec. 16, 2021

    - Philip van Doorn

  12. Brooks Automation stock price target raised to $155 from $139 at Needham

    7:16 a.m. Nov. 17, 2021

    - Tomi Kilgore

  13. The Stock Market Is Tanking. These 5 Stocks Are Not.

    1:23 p.m. Sept. 20, 2021

    - Barron's Online

  15. Brooks Automation to sell its semiconductor solutions business for $3.0 bln in cash to Thomas H. Lee Partners

    6:32 a.m. Sept. 20, 2021

    - Tomi Kilgore

  16. Brooks Automation stock price target raised to $146 from $115 at KeyBanc Capital

    6:05 a.m. Sept. 7, 2021

    - Tomi Kilgore

  17. Brooks Automation stock price target cut to $114 from $130 at Needham

    5:59 a.m. Aug. 6, 2021

    - Tomi Kilgore

  18. Brooks Automation stock price target raised to $130 from $110 at Needham

    6:49 a.m. May 11, 2021

    - Tomi Kilgore

  19. Brooks Automation stock price target raised to $99 from $75 at KeyBanc Capital

    6:58 a.m. Feb. 3, 2021

    - Tomi Kilgore

  20. Brooks Automation started at overweight with $71 stock price target at KeyBanc Capital

    7:29 a.m. Nov. 10, 2020

    - Tomi Kilgore

  21. Loading more headlines...
/news/nonmarketwatch/company/us/azta

Other News on AZTA

  1. 10-Q: AZENTA, INC.

    5:27 p.m. May 10, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-Q: AZENTA, INC.

    5:53 p.m. Feb. 9, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  3. 10-K: AZENTA, INC.

    10:15 a.m. Nov. 25, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Azenta, Inc. (AZTA) Q4 2022 Earnings Call Transcript

    10:17 p.m. Nov. 14, 2022

    - Seeking Alpha

  6. Top 5 3rd Quarter Trades of Sturgeon Ventures LLP

    1:00 p.m. Nov. 3, 2022

    - GuruFocus.com

  7. Tower House Partners LLP's Top 5 Sells of the 2nd Quarter

    11:00 p.m. Aug. 15, 2022

    - GuruFocus.com

At a Glance

Azenta, Inc.

200 Summit Drive

6th floor

Burlington, Massachusetts 01803

Phone

1 9782622400

Industry

Semiconductors

Sector

Technology

Fiscal Year-end

09/2023

View SEC Filings

Revenue

$555.50M

Net Income

$-11.29M

2022 Sales Growth

8.1%

Employees

3,100

Annual Report for AZTA

/news/pressrelease/company/us/azta

Press Releases on AZTA

  6. Azenta Publishes its Environmental, Social, & Governance (ESG) Report

    5:15 p.m. March 7, 2023

    - PR Newswire - PRF

  7. Azenta to Participate in Upcoming Investor Conferences

    5:05 p.m. Feb. 28, 2023

    - PR Newswire - PRF

  9. Ansa Bio Appoints Dr. Matthew McManus as Chair of the Board

    9:00 a.m. Feb. 22, 2023

    - BusinessWire - BZX

  14. Azenta to participate in the 25th Annual Needham Growth Conference

    8:55 a.m. Jan. 5, 2023

    - PR Newswire - PRF

  15. Azenta Announces $500 Million Accelerated Share Repurchase Agreement

    8:15 a.m. Nov. 23, 2022

    - PR Newswire - PRF

  20. Azenta to participate in the Stephens Annual Investment Conference

    9:30 a.m. Nov. 9, 2022

    - PR Newswire - PRF

  21. Loading more headlines...
Link to MarketWatch's Slice.